ѻý

<ѻý class="page-title">Meeting Coverage

SABCS Video Pearls: Metastatic Breast Cancer

<ѻý class="page-description">San Antonio Breast Cancer Symposium
Exercise Improved Quality of Life for Metastatic Breast Cancer Patients

In trial, intervention group reported decreased pain, fatigue, shortness of breath

image
<ѻý class="section_title">Latest SABCS Video Pearls: Metastatic Breast Cancer Meeting Coverage
MeCo Score May Predict Metastatic Progression in Breast Cancer

Seeing whether it can predict response to antifibrotic therapies is next step

January 5, 2024
Financial Toxicity Among Single Mothers With Metastatic Breast Cancer

Diagnosis coupled with financial burden makes for a difficult situation, but help is out there

December 29, 2023
Adding Tucatinib to T-DM1 Shows PFS Benefit in HER2-Positive Breast Cancer

"Clear trend" for improved progression-free survival in subgroup with brain metastases as well

December 22, 2023
Early Change in Breast Cancer Tx Based on Genomic Testing Boosts PFS

HR-positive breast cancer patients with ER mutations doubled their median PFS

December 21, 2021
Genomic Profiling Can Improve Outcomes in Metastatic Breast Cancer

PFS was better when targeted treatment for genomic alterations was supported by ESCAT criteria

December 21, 2021
'Consistent' OS Benefit With Ribociclib in Postmenopausal Women

Halle Moore, MD, discusses the data and clinical implications

December 21, 2021
CKD4/6 Inhibitor in First-Line Treatment for mBC: What Comes Next?

Evidence isn't great to inform a sequencing choice, says Megan Kruse, MD

December 21, 2021
Ipatasertib Disappoints in PIK3CA/AKT1/PTEN-Altered Breast Cancer

Megan Kruse, MD, wonders where it leaves AKT inhibitors in metastatic breast cancer

January 4, 2021
Amcenestrant Active in Postmenopausal, ER-Positive Breast Cancer

Hannah Linden, MD, discusses the encouraging results from the AMEERA-1 trial

December 23, 2020
<ѻý class="section_title"> Latest Oncology/Hematology Meeting Coverage